eFoodSafety.com, Inc. Reports to Shareholders that Bird Flu Virus is Expected to Reach United States within Three Weeks

Business Wire, April 11, 2006

SCOTTSDALE, Ariz. -- Additional Testing on EFSF's Citroxin O2 Continues to Show Complete Eradication of Bird Flu Virus

Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB:EFSF), announced today that the Company's Citroxin O2 ingestible formulation has shown 100% eradication of the H9N2 virus in independent laboratory screenings. The H9N2 virus is the surrogate organism used in laboratory testing for the Bird Flu virus.

Researchers at Prudential Equity Group, LLC have stated that they anticipate the first signs of the Bird Flu virus spreading to the U.S. should be within 3 weeks, with the onset of this potential pandemic reaching California by Fall 2006 and blanketing the entire country before year end.

"eFoodSafety.com, Inc. is acutely aware of the magnitude of this potential pandemic and our key personnel, Robert Bowker, President of Knock-Out Technologies, Ltd., Dr. Richard Goldfarb, President of MedElite, Inc., Tim Matula, and myself are working around the clock seeing to it that these products will be available should such demand reach pandemic proportions," stated Mrs. Gruden.

As previously stated, we are awaiting results from the Citroxin O2 human clinical trials that are currently underway at Bucks County Clinical Research (BCCR) (http://bccrinc.com/), an FDA clinical facility, under the direction of David J. Miller, D.O., FAAP, Executive Director of BCCR and Richard M. Goldfarb, M.D., FACS, Medical Director of Research & Development of BCCR, a Director of eFoodSafety.com, Inc., and President of MedElite, Inc., a wholly-owned subsidiary of eFoodSafety.com, Inc.

"Mr. Bowker and Dr. Goldfarb have been in communication with large multi-billion dollar pharmaceutical companies and I can assure our shareholders we are working to pursue all available avenues for sale of this product as the onset of this potential pandemic appears to be imminent," added Mrs. Gruden.

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus -- EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct, Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to-be-announced in the near future.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.